LONDON, June 30 (Reuters): A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by Britis
Saturday, 19th July, 2025
Support The Morung Express. Your Contributions Matter Click Here
hydroxychloroquine (HCQ)
NEW DELHI, MAY 27 (IANS): One of the pioneers to initiate hydroxychloroquine (HCQ) therapy in COVID-19 positive patients, Dr Sudhir Bhandari, Principal and Controller, Sawai Madho Singh Medical College Hospital
